Current and historical daily PE Ratio for R&G PharmaStudies Co Ltd (
) from 2022 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. R&G PharmaStudies stock (SZSE:301333) PE ratio as of May 26 2024 is 21.8.
More Details
R&G PharmaStudies Co Ltd (SZSE:301333) PE Ratio (TTM) Chart
R&G PharmaStudies Co Ltd (SZSE:301333) PE Ratio (TTM) Historical Data
View and export this data going back to 2022. Start your Free Trial
Total 439
- 1
- 2
- 3
- 4
- 5
| R&G PharmaStudies PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-26 | 21.8 | 2024-03-18 | 26.8 |
| 2024-05-24 | 21.8 | 2024-03-15 | 26.9 |
| 2024-05-23 | 22.3 | 2024-03-14 | 28.7 |
| 2024-05-22 | 23.2 | 2024-03-13 | 24.4 |
| 2024-05-21 | 22.8 | 2024-03-12 | 24.4 |
| 2024-05-20 | 22.3 | 2024-03-11 | 23.2 |
| 2024-05-17 | 21.7 | 2024-03-08 | 21.9 |
| 2024-05-16 | 21.9 | 2024-03-07 | 22.0 |
| 2024-05-15 | 21.8 | 2024-03-06 | 22.9 |
| 2024-05-14 | 22.3 | 2024-03-05 | 23.4 |
| 2024-05-13 | 22.3 | 2024-03-04 | 24.6 |
| 2024-05-10 | 23.1 | 2024-03-01 | 23.9 |
| 2024-05-09 | 24.0 | 2024-02-29 | 24.1 |
| 2024-05-08 | 24.1 | 2024-02-28 | 23.8 |
| 2024-05-07 | 24.2 | 2024-02-27 | 24.6 |
| 2024-05-06 | 24.5 | 2024-02-26 | 24.2 |
| 2024-04-30 | 23.9 | 2024-02-23 | 24.0 |
| 2024-04-29 | 24.2 | 2024-02-22 | 24.1 |
| 2024-04-26 | 22.7 | 2024-02-21 | 24.4 |
| 2024-04-25 | 21.8 | 2024-02-20 | 23.9 |
| 2024-04-24 | 21.5 | 2024-02-19 | 23.8 |
| 2024-04-23 | 22.4 | 2024-02-08 | 23.3 |
| 2024-04-22 | 21.9 | 2024-02-07 | 21.1 |
| 2024-04-19 | 24.8 | 2024-02-06 | 21.5 |
| 2024-04-18 | 25.6 | 2024-02-05 | 20.7 |
| 2024-04-17 | 26.5 | 2024-02-02 | 20.6 |
| 2024-04-16 | 25.8 | 2024-02-01 | 21.7 |
| 2024-04-15 | 27.5 | 2024-01-31 | 22.2 |
| 2024-04-12 | 28.6 | 2024-01-30 | 23.0 |
| 2024-04-11 | 28.7 | 2024-01-29 | 23.8 |
| 2024-04-10 | 29.1 | 2024-01-26 | 24.3 |
| 2024-04-09 | 28.7 | 2024-01-25 | 25.1 |
| 2024-04-08 | 27.3 | 2024-01-24 | 23.9 |
| 2024-04-03 | 26.9 | 2024-01-23 | 24.3 |
| 2024-04-02 | 26.3 | 2024-01-22 | 24.3 |
| 2024-04-01 | 26.3 | 2024-01-19 | 26.0 |
| 2024-03-29 | 24.9 | 2024-01-18 | 26.2 |
| 2024-03-28 | 24.2 | 2024-01-17 | 26.2 |
| 2024-03-27 | 23.0 | 2024-01-16 | 27.3 |
| 2024-03-26 | 23.6 | 2024-01-15 | 27.5 |
| 2024-03-25 | 24.5 | 2024-01-12 | 27.5 |
| 2024-03-22 | 24.6 | 2024-01-11 | 28.3 |
| 2024-03-21 | 25.6 | 2024-01-10 | 27.5 |
| 2024-03-20 | 26.2 | 2024-01-09 | 27.8 |
| 2024-03-19 | 26.1 | 2024-01-08 | 28.1 |
R&G PharmaStudies Co Ltd (SZSE:301333) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
R&G PharmaStudies Co Ltd
ISIN : CNE100005K44
Share Class Description:
SZSE:301333: Class ACompare
Compare
Traded in other countries / regions
301333.China IPO Date
2022-08-02Description
R&G PharmaStudies Co Ltd is a clinical trial outsourcing service provider. It offers full-chain clinical research outsourcing services, serving global pharmaceutical and medical device companies and scientific research institutions.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers